chevron_leftBack
As of 24 April 2025, CSPC Innovation Pharmaceutical Co., Ltd. has a market cap of $8.55B USD, ranking #1924 globally and #253 in China. It ranks #139 in the Consumer Defensive sector, and #34 in the Packaged Foods industry.
Key Stats
Market Cap
$8.55BUSD
62.32B CNY
Enterprise Value
$8.42BUSD
61.39B CNY
Revenue (TTM)
$271.82MUSD
1.98B CNY
EBITDA (TTM)
-$8.29MUSD
-60.39M CNY
Net Income (TTM)
$7.37MUSD
53.73M CNY
EBITDA Margin
-3%
Profit Margin
2.7%
PE Ratio
1159.9
Company Profile
Country (HQ)
Sector
Consumer Defensive
Industry
Packaged Foods
CEO
Bing Yao
open_in_new
Employees
2,487
Founded
2006
Website
xnwpharma.net
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -2.6% | 3.5% | 17% | 55% | 42% | 45% |
Upcoming Earnings
Earnings Date
Thu, Apr 24
Today
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
300765
石药集团新诺威制药股份有限公司 Class A
ISIN: CNE100003K04
Shares Out.:
Shares Outstanding:
1.235B1
Shares Float:
305.796M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
44.75 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About CSPC Innovation Pharmaceutical Co., Ltd.
CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, APIs, and functional foods in China and internationally. It offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dihydroxyphylline, theobromine, pentoxifylline, doxofylline, and raw enzymes; and health food products, such as Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, etc. The company was founded in 2006 and is headquartered in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC NBP Pharmaceutical Co., Ltd.
